Search Prime Grants

R13FD008743

Project Grant

Overview

Grant Description
Srnt 2026 annual meeting - project summary

The Society for Research on Nicotine and Tobacco (SRNT) is the only international scientific society dedicated exclusively to the field of nicotine and tobacco research.

In fiscal 2025, SRNT has nearly 1,200 members from more than 40 countries, with approximately 85 percent of those members being affiliated with U.S. academic, research, government, advocacy, and related organizations.

The overall objective of the SRNT annual meeting is to stimulate advancement in the field of nicotine and tobacco research through the presentation of timely and cutting-edge research, discussion, and networking.

It is the hallmark conference in the field where investigators, advocates, and policymakers can learn about the latest scientific findings, including novel products in the marketplace and effective interventions and policies to reduce tobacco use in the U.S. and in other countries.

The SRNT annual meeting provides a crucial venue for the presentation of the rapidly evolving tobacco regulatory science research findings to the major keyholders in research and policy.

The aims of this conference grant are to:

1) Ensure that tobacco regulatory science content is presented in ways that are maximally informative to FDA and to researchers in the field; and

2) To support the career of trainees and early career investigators in tobacco regulatory science via opportunities for special oral sessions, professional development forums, travel awards, and other recognition.

To meet both aims, SRNT’s program committee meets regularly throughout the year to plan the content and format of the SRNT 2026 annual meeting, aligning the presentation of scientific content with research priorities in the Tobacco Regulatory Science Program (TRSP).

The committee will curate paper sessions on specific topics that highlight advances in the area, foster scientific discussion and debate, and stimulate collaboration across researchers.

The conference grant will also support at least 20 travel awards for trainees and early career investigators presenting on content related to the CTP and NIH TRSP research priorities.

These interactions will facilitate the development of novel questions and approaches to tobacco regulatory science research while supporting the careers of future researchers in this important research discipline.
Funding Goals
TO ASSIST INSTITUTIONS AND ORGANIZATIONS, TO ESTABLISH, EXPAND, AND IMPROVE RESEARCH, DEMONSTRATION, EDUCATION AND INFORMATION DISSEMINATION ACTIVITIES, ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), BIOLOGICS, BLOOD AND BLOOD PRODUCTS, THERAPEUTICS, VACCINES AND ALLERGENIC PROJECTS, DRUG HAZARDS, HUMAN AND VETERINARY DRUGS, CLINICAL TRIALS ON DRUGS AND DEVICES FOR ORPHAN PRODUCTS DEVELOPMENT, NUTRITION, SANITATION AND MICROBIOLOGICAL HAZARDS, MEDICAL DEVICES AND DIAGNOSTIC PRODUCTS, RADIATION EMITTING DEVICES AND MATERIALS, FOOD SAFETY AND FOOD ADDITIVES. THESE PROGRAMS ARE SUPPORTED DIRECTLY OR INDIRECTLY BY THE FOLLOWING CENTERS AND OFFICES: CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH), CENTER FOR VETERINARY MEDICINE (CVM), CENTER FOR FOOD SAFETY AND APPLIED NUTRITION (CFSAN), NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR), THE OFFICE OF ORPHAN PRODUCTS DEVELOPMENT (OPD), THE CENTER FOR TOBACCO PRODUCTS (CTP), AND OFFICE OF REGULATORY AFFAIRS (ORA), AND THE OFFICE OF THE COMMISSIONER (OC). SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAMS: TO STIMULATE TECHNOLOGICAL INNOVATION, TO ENCOURAGE THE ROLE OF SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION BY MINORITY AND DISADVANTAGED PERSONS IN TECHNOLOGICAL INNOVATION. FUNDING SUPPORT FOR SCIENTIFIC CONFERENCES THAT ARE RELEVANT TO THE FDA SCIENTIFIC MISSION AND PUBLIC HEALTH ARE ALSO AVAILABLE.
Place of Performance
Windsor, Wisconsin 535989671 United States
Geographic Scope
Single Zip Code
Society For Research On Nicotine & Tabacco was awarded Project Grant R13FD008743 worth $50,000 from Center for Tobacco Products in March 2026 with work to be completed primarily in Windsor Wisconsin United States. The grant has a duration of 1 year and was awarded through assistance program 93.103 Food and Drug Administration Research. The Project Grant was awarded through grant opportunity FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 3/5/26

Period of Performance
3/1/26
Start Date
2/28/27
End Date
18.0% Complete

Funding Split
$50.0K
Federal Obligation
$0.0
Non-Federal Obligation
$50.0K
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R13FD008743

Additional Detail

Award ID FAIN
R13FD008743
SAI Number
R13FD008743-154247110
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75FDA1 FDA Office of Acquisitions and Grants Services
Funding Office
75DKKI FDA CENTER FOR TOBACCO PRODUCTS
Awardee UEI
NTLJSMEBGQG3
Awardee CAGE
1YFZ9
Performance District
WI-02
Senators
Tammy Baldwin
Ron Johnson
Modified: 3/5/26